Literature DB >> 11738291

Increased production of inflammatory cytokines in patients with silent myocardial ischemia.

A Mazzone1, C Cusa, I Mazzucchelli, M Vezzoli, E Ottini, R Pacifici, P Zuccaro, C Falcone.   

Abstract

OBJECTIVES: The aim of the study was to examine the inflammatory cytokines in patients with myocardial ischemia to evaluate whether silent ischemia patients exhibit any particular cytokine pattern.
BACKGROUND: Silent myocardial ischemia is frequently observed in patients with coronary artery disease. Various endogenous mechanisms control a patient's perceived intensity of pain. Among them, the inflammatory process and the related cytokine production are known to modulate the threshold for activating the primary afferent nociceptors.
METHODS: Seventy-eight patients with reproducible exercise-induced myocardial ischemia were studied: 34 symptomatic patients, with rest and/or stress angina; 44 asymptomatic patients, with no symptoms during daily life activities or during positive exercise stress test. Venous blood samples were taken from all patients to evaluate the expression of CD11b receptors both on neutrophils and monocytes. Frozen plasma samples (at -80 degrees C) were used to quantify the anti-inflammatory (interleukin-4 and -10, transforming growth factor-beta) and the proinflammatory cytokines (tumor necrosis factor-alpha, interferon-gamma, interleukin-1beta and -6).
RESULTS: In asymptomatic patients lower CD11b receptor expression and higher concentration of anti-inflammatory cytokines were observed. Proinflammatory cytokine production was similar in the two groups.
CONCLUSIONS: The data suggest that an "anti-inflammatory pattern" of cytokine production correlates with silent ischemia and that the immune and inflammatory system activation may be crucial for angina symptoms.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11738291     DOI: 10.1016/s0735-1097(01)01660-6

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  10 in total

Review 1.  Diagnostic and prognostic value of ambulatory ECG (Holter) monitoring in patients with coronary heart disease: a review.

Authors:  C Michael Gibson; Lauren N Ciaglo; Matthew C Southard; Shaun Takao; Caitlin Harrigan; Jason Lewis; Jason Filopei; Michelle Lew; Sabina A Murphy; Jacqueline Buros
Journal:  J Thromb Thrombolysis       Date:  2007-04       Impact factor: 2.300

2.  Protein Cytokines, Cytokine Gene Polymorphisms, and Potential Acute Coronary Syndrome Symptoms.

Authors:  Sahereh Mirzaei; Larisa Burke; Anne G Rosenfeld; Susan Dunn; Jennifer R Dungan; Katherine Maki; Holli A DeVon
Journal:  Biol Res Nurs       Date:  2019-06-25       Impact factor: 2.522

Review 3.  Silent myocardial ischemia: recent developments.

Authors:  Peter F Cohn
Journal:  Curr Atheroscler Rep       Date:  2005-03       Impact factor: 5.113

4.  Long term outcome in patients with silent versus symptomatic ischaemia during dobutamine stress echocardiography.

Authors:  E Biagini; A F L Schinkel; J J Bax; V Rizzello; R T van Domburg; B J Krenning; M Bountioukos; C Pedone; E C Vourvouri; C Rapezzi; A Branzi; J R T C Roelandt; D Poldermans
Journal:  Heart       Date:  2005-06       Impact factor: 5.994

5.  Silent myocardial ischemia: Current perspectives and future directions.

Authors:  Amany H Ahmed; Kj Shankar; Hossein Eftekhari; Ms Munir; Jillian Robertson; Alan Brewer; Igor V Stupin; S Ward Casscells
Journal:  Exp Clin Cardiol       Date:  2007

6.  Heart rate recovery after exercise is a predictor of silent myocardial ischemia in patients with type 2 diabetes.

Authors:  Tomohide Yamada; Takashi Yoshitama; Kunihiko Makino; Tetsuo Lee; Fumihiko Saeki
Journal:  Diabetes Care       Date:  2011-01-25       Impact factor: 19.112

7.  Ambulatory and silent myocardial ischemia in women with coronary microvascular dysfunction: Results from the Cardiac Autonomic Nervous System study (CANS).

Authors:  Rajasree Roy; Haider Aldiwani; Navid Darouian; Shilpa Sharma; Tina Torbati; Janet Wei; Michael D Nelson; Chrisandra Shufelt; Margo B Minissian; Lian Li; C Noel Bairey Merz; Puja K Mehta
Journal:  Int J Cardiol       Date:  2020-04-19       Impact factor: 4.039

8.  Cardiology co-management of rheumatoid arthritis patients with coronary artery disease as an intervention reduces hospitalization rates and adverse event occurrence.

Authors:  Jorge D Guerra; Andres Belmont De Santiago; Shirley Reed; Kendall P Hammonds; Courtney Shaver; Robert J Widmer; Beth A Scholz
Journal:  Clin Rheumatol       Date:  2022-08-16       Impact factor: 3.650

9.  Comparison of Incidence of Myocardial Infarction in Patients With Rheumatoid Arthritis and Diabetes Mellitus.

Authors:  Azka Ali; Akhtar Ali; Dilpat Kumar; Ravi Kumar; Kanwal Elahi; Fnu Suman; Zauraiz Anjum; Payal Tharwani; Maha Jahangir; Amber Rizwan
Journal:  Cureus       Date:  2021-06-17

10.  Tacrolimus ameliorates functional disturbances and oxidative stress in isoproterenol-induced myocardial infarction.

Authors:  Arash Khorrami; Mojtaba Hammami; Mehraveh Garjani; Nasrin Maleki-Dizaji; Alireza Garjani
Journal:  Daru       Date:  2014-10-14       Impact factor: 3.117

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.